Ahmet Zülfikar AKELMA, Kadir Okhan AKIN, Şamil HIZLI, Osman ÖZDEMİR, Ayhan ABACI

Relation of total homocysteine level with metabolic and anthropometric variables in obese children and adolescents

To evaluate the total homocysteine (tHcy) level, a risk factor for atherosclerosis, atherothrombosis, and insulin resistance, for sex and pubertal state differences in obese children. Its relationship with metabolic and anthropometric parameters was also investigated. Materials and methods: The study involved obese children with a body mass index (BMI) above the 95th percentile who presented with the complaint of excessive weight gain, and healthy children with a BMI below the 85th percentile. Results: The study included 100 obese (mean age: 10.2 ± 2.7 years) and 71 healthy nonobese (mean age: 10.9 ± 2.6) children. A comparison of the data from the obese group and the control group revealed that the differences in BMI, BMI standard deviation score, tHcy, total cholesterol, triglyceride (TG), insulin, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and homeostasis model assessment-insulin resistance (HOMA-IR) levels were statistically significant (P < 0.05). In the obese group, the tHcy level was statistically significantly correlated with age and BMI, TG, and HDL levels (P < 0.05), while it was not statistically significantly correlated with total cholesterol, LDL, fasting glucose, insulin, or HOMA-IR levels (P > 0.05). Conclusion: The results of this study showed that the tHcy level was higher in obese children than in healthy children. However, the tHcy level was not significantly correlated with insulin resistance in obese children. Obese children should be routinely screened for high tHcy levels due to the potential atherosclerosis risks, and patients with high tHcy levels should be treated.

Anahtar Kelimeler:

Key words: Atherosclerosis, homocysteine, insulin resistance, obesity, puberty

Relation of total homocysteine level with metabolic and anthropometric variables in obese children and adolescents

Keywords:

Key words: Atherosclerosis, homocysteine, insulin resistance, obesity, puberty,

PDF

___

Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity: public-health crisis, common sense cure. Lancet 2002; 360: 473-82. 2. Spiotta RT, Luma GB. Evaluating obesity and cardiovascular risk factors in children and adolescents. Am Fam Physician 2008; 78: 1052-8. 3. Haslam DW, James WP. Obesity. Lancet 2005; 366: 1197-209. 4. Urbina E. Noninvasive assessment of target organ injury in children with metabolic syndrome. J Cardiometab Syndr 2006; 1: 277-81.
Marinou K, Tousoulis D, Antonopoulos AS, Stefanadi E, Stefanadis C. Obesity and cardiovascular disease: from pathophysiology to risk stratifi cation. Int J Cardiol 2010; 138: 3-8.
Wang TJ, Larson MG, Levy D, Benjamin EJ, Kupka MJ, Manning WJ et al. C-reactive protein is associated with subclinical epicardial coronary calcifi cation in men and women: the Framingham Heart Study. Circulation 2002; 106: 1189-91. 7. Beauloye V, Zech F, Tran HT, Clapuyt P, Maes M, Brichard SM. Determinants of early atherosclerosis in obese children and adolescents. J Clin Endocrinol Metab 2007; 92: 3025-32. 8. Çoban E, Yılmaz A, Sarı R. Th e eff ect of weight loss on the mean platelet volume in obese patients. Platelets 2007; 18: 212- 6.
Kazemi MB, Eshraghian K, Omrani GR, Lankarani KB, Hosseini E. Homocysteine level and coronary artery disease. Angiology 2006; 57: 9-14.
Semiz S, Rota S, Özdemir Ö, Özdemir A, Kaptanoğlu B. Are C-reactive protein and homocysteine cardiovascular risk factors in obese children and adolescents? Pediatr Int 2008; 50: 419-23.
Tavil Y, Sen N, Yazıcı HU, Hızal F, Abacı A, Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Th romb Res 2007; 120: 245-50.
Kumbasar SD, Dinçer I, Ertas F, Güleç S, Erol C, Akyurek Ö et al. Hyperhomocysteinemia and restenosis. J Cardiovasc Risk 2001; 8: 9-13.
Martos R, Valle M, Morales R, Canete R, Gavilan MI, Sanchez- Margalet V. Hyperhomocysteinemia correlates with insulin resistance and low-grade systemic infl ammation in obese prepubertal children. Metabolism 2006; 55: 72-7.
Golbahar J, Aminzadeh MA, Kassab SE, Omrani GR. Hyperhomocysteinemia induces insulin resistance in male Sprague-Dawley rats. Diabetes Res Clin Pract 2007; 76: 1-5.
Yılmaz N, Pektaş M, Tonguc E, Kilic S, Gulerman C, Gungor T et al. Th e correlation of plasma homocysteine with insulin resistance in polycystic ovary syndrome. J Obstet Gynaecol Res 2008; 34: 384-91.
Zhu W, Huang X, Li M, Neubauer H. Elevated plasma homocysteine in obese schoolchildren with early atherosclerosis. Eur J Pediatr 2006; 165: 326-31.
Zappalla FR, Gidding SS. Lipid management in children. Endocrinol Metab Clin North Am 2009; 38: 171-83.
Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 2002; 11: 1-190.
American Academy of Pediatrics. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992; 89: 525-84.
Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-7.
Valerio G, Licenziati MR, Iannuzzi A, Franzese A, Siani P, Riccardi G et al. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr Metab Cardiovasc Dis 2006; 16: 279-84.
De Laet C, Wautrecht JC, Brasseur D, Dramaix M, Boeynaems JM, Decuyper J et al. Plasma homocysteine concentration in a Belgian school-age population. Am J Clin Nutr 1999; 69: 968- 72.
Vilaseca MA, Moyano D, Ferrer I, Artuch R. Total homocysteine in pediatric patients. Clin Chem 1997; 43: 690-2.
Brasileiro RS, Escrivao MA, Taddei JA, D’Almeida V, Ancona- Lopez F, Carvalhaes JT. Plasma total homocysteine in Brazilian overweight and non-overweight adolescents: a case-control study. Nutr Hosp 2005; 20: 313-9.
Martinez Laborda S, Salazar Garcia-Blanco MI, Rodriguez Rigual M, Baldellou Vazquez A. Total homocysteine levels in children with diabetes type 1. Conditional factors. An Pediatr (Barc) 2008; 68: 264-8.
Papandreou D, Rousso I, Makedou A, Arvanitidou M, Mavromichalis I. Association of blood pressure, obesity and serum homocysteine levels in healthy children. Acta Paediatr 2007; 96: 1819-23.
Üstündağ B, Güngör S, Aygün AD, Turgut M, Yılmaz E. Oxidative status and serum leptin levels in obese prepubertal children. Cell Biochem Funct 2007; 25: 479-83.
Narin F, Atabek ME, Karakukcu M, Narin N, Kurtoğlu S, Gümüş H et al. Th e association of plasma homocysteine levels with serum leptin and apolipoprotein B levels in childhood obesity. Ann Saudi Med 2005; 25: 209-14.
Lin YH, Pao KY, Yang WS, Wu VC, Chen YJ, Lin YL et al. Waist-to-hip ratio correlates with homocysteine levels in male patients with coronary artery disease. Clin Chem Lab Med 2008; 46: 125-30.